Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 748

Sherlock catches $31m with Baidu’s help

Baidu Ventures has helped close a $31m series A round for Harvard-founded Sherlock Biosciences just over a month after the spinout launched with an initial $17.5m tranche.

Apr 25, 2019

Corporates enter Cultivian Sandbox for $135m fund

Corteva Agriscience, ADM, Elanco, Ecolab, Griffith Foods, RD Offutt, Growmark, Koch Ag & Energy, Smithfield Foods and Sumitomo Chemical America all backed the VC firm's latest fund.

Apr 25, 2019

Nocion plays nice to raise $27m

Nocion Therapeutics has raised $27m in a Partners Innovation Fund-backed series A round to develop drugs for pain and inflammation.

Apr 25, 2019

Satsuma snatches $62m in series B round

Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.

Apr 25, 2019

Harness picks up $60m

GV, ServiceNow Ventures and IVP co-led the series B round, which valued the AI-based software testing and deployment platform at $500m.

Apr 25, 2019

EARDG Photonics looks into funding

UAVC has put capital into newly launched UA spinout EARDG Photonics, which integrates technology licensed from another spinout, TIPD, by the same co-founders.

Apr 25, 2019

Slack returns to Astound in series B round

Slack Fund has taken part in a $15.5m series B round that increased the AI-based enterprise software developer's total funding to $27m.

Apr 25, 2019

Nocion finds series A relief

Based on Harvard and Boston Children’s Hospital research, Nocion Therapeutics has raised $27m to develop drugs for pain and inflammation.

Apr 25, 2019

Satsuma squeezes $62m out of series B

Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.

Apr 25, 2019

Norman nods to Bayer offer

Derek Norman has left Syngenta Ventures and joined Bayer Growth Ventures as vice-president, while Colin Steen has replaced him as head of the unit.

Apr 25, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here